9 Results for "

Survivin-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "Survivin-IN-1" in MCE Product Catalog:

Cat. No.: HY-174336
Target:  

Survivin Apoptosis

Research Areas:  

Cancer

Survivin-IN-1 (Compound II₃) is a potent Survivin (a member of the Inhibitor of Apoptosis Protein family) inhibitor with an IC50 value of 8.1 μM against human lung cancer A549 cells and 9.0 μM against breast cancer MCF-7 cells. Survivin-IN-1 reduces Survivin protein levels and induces tumor cell apoptosis. Survivin-IN-1 is promising for research of malignant tumors such as lung cancer and breast cancer [1].
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-N6064
CAS No.: 66663-91-0
Polygalacin D (PGD) is a bioactive compound isolated from Platycodon grandiflorum with anticancer and anti-proliferative properties. PGD suppresses the expression of the IAP family of proteins including survivin, cIAP-1 and cIAP-2 and blocks the PI3K/Akt pathway by inhibiting the phosphorylation of GSK3β, Akt and the expression of PI3K. Polygalacin D induces apoptosis [1]
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-15191
CAS No.: 1228108-65-3
Purity:  99.04%
Synonyms: BI-97C1
Target:  

Bcl-2 Family

Research Areas:  

Cancer

Sabutoclax is a potent and effective Bcl-2 Family (Bcl-2, Bcl-XL, Mcl-1, Bfl-1) inhibitor with IC50s of 0.32 μM, 0.31 μM, 0.20 μM, and 0.62 μM, respectively. Sabutoclax increases Bax, Bim, PUMA and survivin expression .
loading...
    loading...
Cat. No.: HY-178226
CAS No.: 3003834-34-9
PBX-7016 is a DNA topoisomerase I inhibitor and DDX5 degrader. PBX-7016 induces DNA damage and downregulates Survivin, Mcl-1, and XIAP. PBX-7016 exerts a bystander killing effect. PBX-7016 can serve as an ADC payload for the synthesis of ADC. PBX-7016 is applicable to research related to head and neck cancer, non-small cell lung cancer, breast cancer, colorectal cancer, and ovarian cancer [1] .
loading...
    loading...
Cat. No.: HY-173025
Research Areas:  

Neurological Disease

Nurr1 agonist 12 (Compound 37) is the agonist for nuclear receptor-associated protein 1 (Nurr1) that activates the transcriptional activity of Nurr1 with an EC50 of 0.06 μM. Nurr1 agonist 12 activates the human response elements NBRE, NurRE, and DR5 with EC50 of 0.07 μM, 0.027 μM, and 0.014 μM, respectively. Nurr1 agonist 12 induces the expression of Nurr1-regulated neurotrophic genes, such as tyrosine hydroxylase (TH), SOD1/2, BDNF, Sestrin 3, and BIRC5 (Survivin). Nurr1 agonist 12 exhibits neuroprotective efficacy against Paraquat-induced neurotoxicity [1].
loading...
    loading...
Cat. No.: HY-160438B
Target:  

Bcl-2 Family Survivin

Research Areas:  

Cancer

PBX-7011 TFA is a derivative of camptothecin (HY-16560), which inhibits expressions of the cancer related survival genes DDX5, Survivin, Mcl-1 and XIAP in cells FaDu, degrades DDX5 proteins and exhibits anticancer activity [1].
loading...
    loading...
Cat. No.: HY-186213
CAS No.: 3079079-78-7
Research Areas:  

Cancer

Survivin ligand-1 is a ligand for target protein for PROTAC targeting survivin. Survivin ligand-1 can be used for synthesis of PROTAC survivin degrader-1 (HY-186212) [1].
loading...
    loading...
Cat. No.: HY-186212
CAS No.: 3079079-69-6
Target:  

PROTACs Survivin PARP

Research Areas:  

Neurological Disease Cancer

PROTAC survivin degrader-1 is an orally active, CNS-penetrant survivin-targeting PROTAC. PROTAC survivin degrader-1 induces degradation of survivin via the ubiquitin proteasome system. PROTAC survivin degrader-1 can be used for the research of glioblastoma [1].
loading...
    loading...
Cat. No.: HY-P11828
Target:  

Survivin Caspase Apoptosis

Research Areas:  

Cancer

Anticancer agent 324 is a Survivin inhibitor. Anticancer agent 324 competitively binds to Survivin’s linker region and triggers proteasomal IAP degradation. Anticancer agent 324 blocks Borealin binding and chromosomal passenger complex formation, and inhibits Survivin-CRM1 nuclear-cytoplasmic transport. Anticancer agent 324 activates extrinsic (caspase-8) and intrinsic (caspase-9) apoptotic pathways, activates executioner caspases-3 and caspases-7, and arrests cell cycle. Anticancer agent 324 can be used for the research of breast cancer [1].
loading...
    loading...